1Karl S, John C, Henry D, et al. Guidelines for diagnosis and treatment of chronic heart failure : executive summary [ J ]. European Heart Jour- nal, 2005, 26(6) : 1115 -1140.
4Burger A J, Aronson D, Horton D P, et al. Comparison of the effects of dobutamine and nesiritide ( B - type natriuretic peptide) on ventricular ectopy in acutely decompensated ischemicversus nonischemic eardiomy- opathy[ J ]. Am J Cardiol, 2003, 91 ( 11 ) : 1370 - 1372.
8NABEL EG, SELWYN AP, GANZ P. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate [J]. Circulation, 1990, 81(3): 850-859.
9VATNER SF, BAIG H. Importance of heart rate in determining the effects of sympathomimetic amines on regional myocardial function and blood flow in conscious dogs with acute myocardial ischemia[J]. Circ Res, 1979, 45(6): 793 -803.
10ROBERTO F, ANNA C, CLAUDIO C. Anti-ischaemic effect of ivabradine[J]. Pharm Res, 2006, 53(5): 435 -439.
2Almeida JGL, Xavier SS, Garcia MI, et al. Hemodynamic assessment in heart failure: role of physical examination and noninvasive methods[J]. Arq Bras Cardiol,2012,98(1):15-21.
3Foo JYY,Wan Y,Kostner K,et al. NT-ProBNP levels in saliva and its clinical relevance to heart failure[J]. PLoS One,2012,7(10):e48452.
4Marcondes-Braga FG,Gutz IGR,Batista GL, et al. Exhaled Acetone as a new biomarker of heart failure severi-ty[J]. Chest,2012,142(2):457-466.
5Latini R,Masson S. Significance of measurable cardiac troponin by high-sensitivity assays in patients with chronic stable heart failure[J]. Coron Artery Dis,2013,24(8):716-719.
6Cakmak HA,Coskunpinar E,Ikitimur B,et al. The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study [J]. J Cardiovasc Med (Hagerstown),2015,16(6):431-437.
7Krum H,Massie B, Abraham WT, et al. Direct rennin inhibition in addition to or as an atternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: ationale and design of the Aliskiren Trail to Minimize Outcomes in Patients with Heart failure (ATMOSPHERE)study[J]. Eur J Heart Fail,2011,13(1):107-114.
8McMurray JJ,Packer M,Desai AS,et al. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)[J]. Eur J Heart Fail,2013,15(9):1062-1073.
9Krum H,Shi H,Pitt B,et al. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: a-nalysis of the EMPHASIS-HF study[J]. Circ Heart Fail,2013,6(4):711-718.
10Barfacker L,Kuhl A, Hillisch A,et al. Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorti-coid receptor for the treatment of cardiorenal diseases[J], Chem Med Chem,2012,7(8):1385-1403.
